- Home
- OCS vs ULCC Comparison
OCS vs ULCC Comparison
Compare OCS & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | ULCC |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OCS | ULCC |
|---|---|---|
| Price | $21.14 | $5.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | ★ $39.80 | $5.56 |
| AVG Volume (30 Days) | 100.6K | ★ 5.1M |
| Earning Date | 11-10-2025 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $991,999.00 | ★ $3,729,000,000.00 |
| Revenue This Year | $35.00 | $0.37 |
| Revenue Next Year | $874.12 | $14.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.77 |
| 52 Week Low | $14.00 | $2.89 |
| 52 Week High | $23.08 | $10.26 |
Technical Indicators
Market Signals| Indicator | OCS | ULCC |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 54.14 |
| Support Level | $19.12 | $4.89 |
| Resistance Level | $21.86 | $5.57 |
| Average True Range (ATR) | 0.73 | 0.36 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 75.93 | 34.67 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.